Release Date: 06/02/09 11:21 Summary: Assets Under Management Update Price Sensitive: Yes Download Document 55.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%